James H Sabry - Net Worth and Insider Trading

James H Sabry Net Worth

The estimated net worth of James H Sabry is at least $0 dollars as of 2024-09-21. James H Sabry is the Former Executive Chairman of Cytokinetics Inc and owns about 0 shares of Cytokinetics Inc (CYTK) stock worth over $0. Details can be seen in James H Sabry's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James H Sabry has not made any transactions after 2010-06-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of James H Sabry

To

James H Sabry Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James H Sabry owns 1 companies in total, including Cytokinetics Inc (CYTK) .

Click here to see the complete history of James H Sabry’s form 4 insider trades.

Insider Ownership Summary of James H Sabry

Ticker Comapny Transaction Date Type of Owner
CYTK Cytokinetics Inc 2010-06-03 director & President and CEO

James H Sabry Latest Holdings Summary

James H Sabry currently owns a total of 1 stock. James H Sabry owns 0 shares of Cytokinetics Inc (CYTK) as of June 3, 2010, with a value of $0.

Latest Holdings of James H Sabry

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CYTK Cytokinetics Inc 2010-06-03 0 53.78 0

Holding Weightings of James H Sabry


James H Sabry Form 4 Trading Tracker

According to the SEC Form 4 filings, James H Sabry has made a total of 0 transactions in Cytokinetics Inc (CYTK) over the past 5 years. The most-recent trade in Cytokinetics Inc is the sale of 4,167 shares on June 3, 2010, which brought James H Sabry around $73,000.

Insider Trading History of James H Sabry

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James H Sabry Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

James H Sabry Ownership Network

Ownership Network List of James H Sabry

No Data

Ownership Network Relation of James H Sabry

Insider Network Chart

James H Sabry Owned Company Details

What does Cytokinetics Inc do?

Who are the key executives at Cytokinetics Inc?

James H Sabry is the director & President and CEO of Cytokinetics Inc. Other key executives at Cytokinetics Inc include SVP Research & Early Dev Fady Ibraham Malik , EVP & Corp. Development & CBO Robert I Blum , and VP & Chief Accounting Officer Robert Wong .

Cytokinetics Inc (CYTK) Insider Trades Summary

Over the past 18 months, James H Sabry made no insider transaction in Cytokinetics Inc (CYTK). Other recent insider transactions involving Cytokinetics Inc (CYTK) include a net sale of 373,500 shares made by Robert I Blum , a net sale of 183,194 shares made by Fady Ibraham Malik , and a net sale of 40,000 shares made by B Lynne Parshall .

In summary, during the past 3 months, insiders sold 137,437 shares of Cytokinetics Inc (CYTK) in total and bought 0 shares, with a net sale of 137,437 shares. During the past 18 months, 658,744 shares of Cytokinetics Inc (CYTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 658,744 shares.

Cytokinetics Inc (CYTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cytokinetics Inc Insider Transactions

No Available Data

James H Sabry Mailing Address

Above is the net worth, insider trading, and ownership report for James H Sabry. You might contact James H Sabry via mailing address: 280 East Grand Avenue, South San Francisco Ca 94080.

Discussions on James H Sabry

No discussions yet.